us clinical guidance

Urinary tract infection in children and adolescents

Probability-based urine testing, uncontaminated collection, urinalysis-plus-culture diagnosis, local antimicrobial selection, result follow-up and selective imaging.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Children younger than 16 years with possible cystitis, febrile urinary tract infection or pyelonephritis. The UCSF Northern California consortium source is a current institutional consensus pathway, and ACR supplies national specialty guidance for imaging. Neonates, young febrile infants, shock, known complex uropathy, transplant, severe immune compromise and indwelling urinary devices require age- or condition-specific local pathways.

The Bottom Line

  • Test urine when age, fever pattern, urinary symptoms or absence of another source creates meaningful UTI probability; avoid indiscriminate cultures in children whose presentation strongly supports another diagnosis because asymptomatic bacteriuria and contamination can cause harm.
  • Collect urine before antibiotics when this does not delay stabilization. Use catheterization or suprapubic aspiration when an uncontaminated specimen is required from a non-toilet-trained child, and clean catch for a toilet-trained child; do not use a positive bag culture to establish UTI.
  • Diagnose UTI from compatible symptoms or fever together with pyuria and clinically significant growth of a urinary pathogen from an appropriately collected specimen, rather than treating culture growth without inflammatory or clinical context.
  • Select empiric antibiotics from age, illness severity, allergy, prior isolates, recent exposure and the local antibiogram, then review the culture promptly and narrow, change or stop treatment when organism, susceptibility or specimen quality requires it.
  • Use imaging selectively. Renal and bladder ultrasonography is often appropriate after a first febrile UTI in a child younger than 24 months or when disease is atypical or recurrent; routine CT, nuclear scanning or voiding studies are not a default for every first infection.

Practical clinical workflow

1
Document fever, dysuria, frequency, new incontinence, abdominal or flank pain, vomiting, prior UTI and organisms, antibiotics, bowel and bladder habits, congenital urinary disease and family renal history.
2
Assess hydration, perfusion, blood pressure, growth and abdominal, flank, genital and spine findings; route a young febrile infant or systemically ill child to the local sepsis or febrile-infant pathway.
3
Obtain urinalysis and culture using the least invasive collection method that still yields a decision-quality specimen; record the method because colony-count interpretation depends on how urine was collected.
4
Start oral treatment when the child is stable and able to take medicine, or parenteral treatment and observation or admission when sepsis, dehydration, vomiting, unreliable follow-up or resistant-organism risk makes outpatient therapy unsafe.
5
Track every culture to final result, contact the family with any change, reassess a child who fails to improve within 48 to 72 hours and address constipation or dysfunctional voiding to reduce recurrence.

Safety boundaries and escalation

  • Shock, altered mental state, poor perfusion, persistent vomiting, oliguria or suspected obstructed infected system requires urgent hospital and urology or critical-care assessment.
  • Mixed growth, multiple organisms or low-probability culture positivity may represent contamination; repeat a properly collected specimen rather than extending unnecessary antibiotics in a clinically well child.
  • Persistent fever or pain after 48 to 72 hours raises concern for resistance, nonadherence, abscess, obstruction or an incorrect diagnosis and should trigger clinical reassessment rather than automatic antibiotic prolongation.
  • Recurrent febrile UTI, abnormal ultrasound, poor growth, hypertension or impaired kidney function warrants coordinated pediatric nephrology or urology evaluation according to the local pathway.

Localization

There is no current AAP national diagnostic guideline replacing the retired race-containing 2011 infant UTI guideline. This summary therefore labels UCSF鈥檚 February 2025 consensus as a Northern California implementation source and uses ACR 2023 only for imaging appropriateness.

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Northern California Pediatric Hospital Medicine Consortium, UCSF Benioff Children's HospitalsConsensus Guidelines for Management of Pediatric Urinary Tract Infection (UTI)Last updated February 11, 2025 路 updated 2025-02-11 路 accessed 2026-08-20
    view source
  2. American College of RadiologyACR Appropriateness Criteria庐 Urinary Tract Infection鈥揅hildRevised 2023 路 updated 2023-01-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.